+10.1% · 90d
$5.76
-0.28 (-4.64%)
After-Hours $5.72(-0.04)
News
(1)April 2026
IMRX provides proxy guidance for annual board and auditor elections
IMRXImmuneering Corp
# 📄 What This Proxy Statement Is 📜 This is a definitive Proxy Statement (DEF 14A), which is a foundational document required by the SEC. Think of it as the annual "rulebook" for shareholders, detailing everything that will be voted upon at the upcoming Annual Meeting of Stockholders. The purpose
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%